Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women

NCT00330096 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT00330096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
April 30, 2009
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, osteopenia